JAN 18, 2016 8:42 AM PST

Eye Movement and Alzheimer's Disease

Alzheimer’s disease (AD) and other forms of dementia are on the rise. There is no known cause of AD and there isn’t even a definitive way to diagnose the disease until after a person has died. A key area in neuroscience research is the search for an early test for AD so that patients and their families can have time to arrange care and look for ways to deal with the memory loss and other factors.
New research could identify Alzheimer's disease earlier

The most recent figures show that approximately 5.1 million Americans might be suffering from the effects of Alzheimer’s disease. And those figures are going up. Current research from the National Institute on Aging indicates that the prevalence of Alzheimer's disease doubles every five years beyond age 65.  By the year 2050 the costs of treating AD could rise to $1.1 trillion, up from the $226 billion estimated through the year 2015. Finding a way to test for the disease has become a crucial part of the research surrounding Alzheimer’s disease. 
 
Chilean neurologists however may have found a process for diagnosing Alzheimer's disease early, even before memory loss and other symptoms develop. Researchers at Chile's Biomedical Neuroscience Institute (BNI) believe they can identify early stages of dementia and even some other psychiatric and neurological diseases by observing eye movement patterns and the brain's electrical activity. Using a computer simulation game with virtual reality technology the neurologists in Chile studied patients playing along in a game where they  had to navigate through a virtual landscape and find "keys" to complete a task. Lead neurologist Enzo Brunetti said the tests were able to detect very early signs of cognitive impairment, even in patients who showed no symptoms. 
 
Brunetti told Reuters, "In this study, what we did was that we applied spatial navigation tasks using a computer, and with the help of a software we examined in detail which were the early functions that became altered in Alzheimer's disease (patients) and focused on a very specific function, linked to the codification and development of cognitive memory, that helps people move through the physical environment. This is one of the cognitive functions that were altered in patients with Alzheimer's and we observed that they were altered from very early stages. Therefore we believe this is a biomarker for the disease, which would give us an opportunity to shed light on an early diagnosis for this disease." 

The team in Chile also fitted study participants with caps containing electrodes and conducted EEG testing while the patients were navigating through the game. This monitoring, along with recording the eye movements of patients convinced Brunetti that diagnosing AD before significant memory loss and cognitive impairment is vital to helping patients and that a larger clinical trial is necessary to fine tune the process. Take a look at the video below to learn more about the study and how it could impact dementia patients and their families.
 
 
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
OCT 02, 2020
Clinical & Molecular DX
Detecting Dystonia in the Blink of an AI
OCT 02, 2020
Detecting Dystonia in the Blink of an AI
A team of scientists have created a diagnostic tool, powered by artificial intelligence (AI), that can pick up on the su ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
NOV 01, 2020
Neuroscience
Depression Increases Risk of Having a Stroke
NOV 01, 2020
Depression Increases Risk of Having a Stroke
Researchers in Alabama have found that people who suffer from multiple depressive symptoms are at an increased risk of h ...
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 20, 2020
Neuroscience
The Link Between Sleep Apnea and Autoimmune Disease
NOV 20, 2020
The Link Between Sleep Apnea and Autoimmune Disease
Researchers from the University of Georgia have found more evidence for the link between obstructive sleep apnea (OSA) a ...
Loading Comments...